Tag Archives: Rhythm Pharmaceuticals

Rhythm Pharmaceuticals director Jennifer Good sells over $1.6m in stock, a move that has sparked curiosity and analysis within the pharmaceutical industry. This significant transaction raises questions about the company’s current financial standing and future prospects, especially in the context of its focus on developing treatments for rare diseases. Jennifer …

Read More »